Hiroaki Saito
Planegg, BY 82152, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Tgif1-deficiency impairs osteoclast differentiation through PP2A-mediated ERK1/2 dephosphorylation and attenuates bone loss in mice.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: January 16, 2025
Tgif1-deficiency impairs cytoskeletal architecture in osteoblasts by activating PAK3 signaling.
Journal: eLife
Published: April 25, 2024
SFRP2 Overexpression Induces an Osteoblast-like Phenotype in Prostate Cancer Cells.
Journal: Cells
Published: November 18, 2022
R-spondin 3 deletion induces Erk phosphorylation to enhance Wnt signaling and promote bone formation in the appendicular skeleton.
Journal: eLife
Published: October 12, 2022
Muscle and Bone Defects in Metastatic Disease.
Journal: Current osteoporosis reports
Published: July 25, 2022
Antagonizing microRNA-19a/b augments PTH anabolic action and restores bone mass in osteoporosis in mice.
Journal: EMBO molecular medicine
Published: October 20, 2020
All-suture anchor pullout results in decreased bone damage and depends on cortical thickness.
Journal: Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA
Published: December 08, 2019
Breast cancer bone metastases are attenuated in a Tgif1-deficient bone microenvironment.
Journal: Breast cancer research : BCR
Published: November 28, 2019
Sclerostin inhibition alleviates breast cancer-induced bone metastases and muscle weakness.
Journal: JCI insight
Published: April 10, 2019
TG-interacting factor 1 (Tgif1)-deficiency attenuates bone remodeling and blunts the anabolic response to parathyroid hormone.
Journal: Nature communications
Published: July 11, 2017
Last Updated: 09/26/2026